CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer
- PMID: 29928961
- DOI: 10.1016/j.canlet.2018.06.018
CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer
Abstract
Sulfasalazine has been repurposed to induce ferroptotic cancer cell death via inhibition of xc--cystine/glutamate antiporter (xCT). However, cancer cells are capable of developing mechanisms to evade cell death. Therefore, we sought to determine the molecular mechanisms underlying resistance to sulfasalazine-induced ferroptosis in head and neck cancer (HNC). The effects of sulfasalazine and pioglitazone were tested in various HNC cell lines. The effects of these drugs and inhibition and overexpression of CISD2 gene were determined by evaluating viability, cell death, lipid ROS production, mitochondrial iron, and mouse tumor xenograft models. SAS induced ferroptotic cell death in HNC at different levels. CISD2 expression showed an association between its expression and ferroptosis resistance. CISD2 overexpression conferred resistance to ferroptosis by sulfasalazine. Silencing CISD2 gene rendered resistant HNC cells susceptible to sulfasalazine-induced ferroptosis, with increased levels of lipid ROS and mitochondrial ferrous iron. Pioglitazone induced over-accumulation of mitochondrial iron and ROS and sensitized resistant HNC cells to sulfasalazine treatment in vitro and in a mouse tumor-xenograft model. CISD2 inhibition overcomes HNC resistance to ferroptotic cell death induced by sulfasalazine via increased accumulation of mitochondrial ferrous iron and lipid ROS.
Keywords: Cancer resistance; Ferroptosis; Nutrient-deprivation autophagy factor-1; Pioglitazone; System xc-cystine/glutamate antiporter.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.Cancer Lett. 2016 Oct 10;381(1):96-103. doi: 10.1016/j.canlet.2016.07.035. Epub 2016 Jul 28. Cancer Lett. 2016. PMID: 27477897
-
Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.Redox Biol. 2017 Apr;11:254-262. doi: 10.1016/j.redox.2016.12.010. Epub 2016 Dec 18. Redox Biol. 2017. PMID: 28012440 Free PMC article.
-
Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis.Theranostics. 2020 Jun 19;10(17):7775-7786. doi: 10.7150/thno.46903. eCollection 2020. Theranostics. 2020. PMID: 32685019 Free PMC article.
-
Ferroptosis as a New Type of Cell Death and its Role in Cancer Treatment.Klin Onkol. 2018 Winter;31(Suppl 2):21-26. doi: 10.14735/amko20182S21. Klin Onkol. 2018. PMID: 31023020 Review. English.
-
Cystine-glutamate antiporter xCT as a therapeutic target for cancer.Cell Biochem Funct. 2021 Mar;39(2):174-179. doi: 10.1002/cbf.3581. Epub 2020 Aug 4. Cell Biochem Funct. 2021. PMID: 32749001 Review.
Cited by
-
Ferroptosis in cancer (Review).Oncol Lett. 2024 May 8;28(1):304. doi: 10.3892/ol.2024.14437. eCollection 2024 Jul. Oncol Lett. 2024. PMID: 38774452 Free PMC article. Review.
-
Understanding the Novel Approach of Nanoferroptosis for Cancer Therapy.Nanomicro Lett. 2024 May 2;16(1):188. doi: 10.1007/s40820-024-01399-0. Nanomicro Lett. 2024. PMID: 38698113 Free PMC article. Review.
-
Molecular mechanisms of mitochondria-mediated ferroptosis: a potential target for antimalarial interventions.Front Cell Dev Biol. 2024 Apr 10;12:1374735. doi: 10.3389/fcell.2024.1374735. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38660623 Free PMC article. Review.
-
Epigenetic regulation of diverse cell death modalities in cancer: a focus on pyroptosis, ferroptosis, cuproptosis, and disulfidptosis.J Hematol Oncol. 2024 Apr 23;17(1):22. doi: 10.1186/s13045-024-01545-6. J Hematol Oncol. 2024. PMID: 38654314 Free PMC article. Review.
-
The role of ferroptosis in radiotherapy and combination therapy for head and neck squamous cell carcinoma (Review).Oncol Rep. 2024 Jun;51(6):79. doi: 10.3892/or.2024.8738. Epub 2024 Apr 19. Oncol Rep. 2024. PMID: 38639185 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical